HLA-G and anemia (phenotype): This study shows that in selected ESRD patients, a CDDP is able to protect the RRF, to maintain urine volume output, to preserve a good nutritional status , to blunt the rapid β2 microglobulin increase, and to allow better control of anemia and calcium-phosphate abnormalities.